Related Experiment Videos

Inconsistent approach to the treatment of chronic digoxin toxicity in the United States

B M Kirrane1, R E Olmedo, L S Nelson

  • 1Department of Emergency Medicine, Yale University School of Medicine, New Haven, Connecticut 06511, USA. barbara.kirrane@yale.edu

Human & Experimental Toxicology
|September 17, 2009
PubMed

Insights

Treatment for chronic digoxin toxicity varies significantly among specialists, impacting patient care. Developing consensus guidelines is crucial for standardized, optimal treatment of digoxin toxicity.

Area of Science:

  • Cardiology
  • Medical Toxicology
  • Emergency Medicine

Background:

  • Lack of evidence-based guidelines for managing chronic mild-to-moderate digoxin toxicity.
  • Digoxin toxicity poses a significant clinical challenge requiring careful management.
  • Variability in clinical practice may lead to suboptimal patient outcomes and increased healthcare costs.

Purpose of the Study:

  • To investigate differences in treatment decisions for chronic digoxin toxicity among various medical specialists.
  • To evaluate specialist approaches to using digoxin-specific antibody fragments (Fab) and patient admission.
  • To identify potential knowledge gaps or differing perspectives influencing clinical practice.

Main Methods:

  • A survey was distributed to cardiologists, emergency physicians, and medical toxicologists.
  • Four hypothetical cases of chronic digoxin toxicity with varying signs and symptoms were presented.
  • Clinicians were asked to make decisions regarding patient admission and treatment with digoxin-specific antibody fragments.

Main Results:

  • Response rates varied by specialty: toxicologists (39%), cardiologists (17%), and emergency physicians (6.7%).
  • Significant differences were observed in the administration of digoxin-specific antibody fragments (Fab): toxicologists (91.5%), emergency physicians (82%), cardiologists (67%).
  • Admission rates also differed: toxicologists (46%), cardiologists (34%), and emergency physicians (28%).

Conclusions:

  • Substantial variations exist among specialists in managing chronic digoxin toxicity.
  • These discrepancies highlight potential differences in understanding or application of current knowledge.
  • Addressing these variations is essential for developing consensus guidelines, improving care quality, and optimizing resource utilization.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...